Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial
Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation…
Ler MaisTocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation…
Ler Mais2023 ISTH update of the 2022 ISTH guidelines for antithrombotic…
Ler MaisType 1 VWD classification revisited: novel insights from combined analysis…
Ler MaisTestes Viscoelásticos na Avaliação de Alterações da Hemostase na Infeção…
Ler Mais